✨ Your Portfolio is fetched and updated from zerodha.
Micro Pharmaceuticals

Parenteral Drugs (India) Ltd. (Inactive)

PDPL

Market Cap
₹10 Cr.
P/E
0.00

Parenteral Drugs (India) Ltd. (Inactive)

FAQs on Parenteral Drugs (India) Ltd. Shareprice

Parenteral Drugs has given lower returns compared to its competitors.
Parenteral Drugs has grown at ~-23.95% over the last 5yrs while peers have grown at a median rate of 17.49%

There is insufficient historical data to gauge this.
Latest PE of Parenteral Drugs is 0

View FAQ's On Business
Growth Table
Balance Sheet
Balance Sheet Snapshot
No data available.
Fund Flow Analysis
  • 1y
  • 3y
  • 5y
  • 10y
  • Increase
  • Decrease
  • Total
No data available.
*Data is as of latest FY end
Profit & Loss
Cash Flow
Cash Flow Analysis
  • 1y
  • 3y
  • 5y
  • 10y
  • Increase
  • Decrease
  • Total
No data available.
Ratios
= Dominant Factor
Quarterly Results
FAQs on Parenteral Drugs (India) Ltd. Financials

Parenteral Drugs balance sheet is weak and might have solvency issues

The debt of Parenteral Drugs is decreasing.
Latest debt of Parenteral Drugs is ₹107 Crs as of Mar-22.
This is less than Mar-21 when it was ₹635 Crs.

The profit is oscillating.
The profit of Parenteral Drugs is -₹76.36 Crs for TTM, -₹121.71 Crs for Mar 2021 and -₹114.07 Crs for Mar 2020.

The company seems to be paying a very low dividend.
Investors need to see where the company is allocating its profits.
Parenteral Drugs latest dividend payout ratio is 0% and 3yr average dividend payout ratio is 0%

Companies resources are majorly tied in miscellaneous assets

View FAQ's On Shareholding
Ideas Dashboard
Timeline
Watchlist
Portfolio
Alerts
Research
Stock Screener
Market
Raw Material
Data feed provided by Accord Fintech